Headquartered in Folsom, California, CGT Global is a leading global provider of human primary cells, stem cells, bone marrow, cord blood, peripheral blood, and disease-state products. Our products are used for research and development, clinical trials, and commercial production of cell and gene therapies (allogeneic or autologous) by academic, biotech, diagnostic, pharmaceutical and contract research organizations (CRO’s).
CGT Global is registered with the U.S. Food and Drug Administration (FDA) and has over a dozen global distribution partners and 3 brick-and-mortar cellular clinics in the United States, outfitted with GMP certified laboratories. It has been ranked by Inc. 500 as one of the fastest growing companies in the U.S.
